Clonal Hematopoiesis Is Associated With Low CD4 Nadir and Increased Residual HIV Transcriptional Activity in Virally Suppressed Individuals With HIV.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
19 04 2022
Historique:
received: 08 02 2021
accepted: 18 08 2021
pubmed: 22 8 2021
medline: 21 4 2022
entrez: 21 8 2021
Statut: ppublish

Résumé

Clonal hematopoiesis, a common age-related phenomenon marked by expansion of cells with clonal hematopoiesis driver mutations, has been associated with all-cause mortality, cancer, and cardiovascular disease. People with HIV (PWH) are at risk for non-AIDS-related comorbidities such as atherosclerotic cardiovascular disease and cancer. In a cross-sectional cohort study, we compared clonal hematopoiesis prevalence in PWH on stable antiretroviral therapy with prevalence in a cohort of overweight individuals and a cohort of age- and sex-matched population controls. The prevalence of clonal hematopoiesis adjusted for age was increased and clone size was larger in PWH compared to population controls. Clonal hematopoiesis is associated with low CD4 nadir, increased residual HIV-1 transcriptional activity, and coagulation factors in PWH. Future studies on the effect of clonal hematopoiesis on the HIV reservoir and non-AIDS-related comorbidities are warranted.

Identifiants

pubmed: 34417800
pii: 6356061
doi: 10.1093/infdis/jiab419
pmc: PMC9016425
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1339-1347

Subventions

Organisme : European Research Council
ID : 833247
Pays : International

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America.

Références

Science. 2020 Mar 27;367(6485):1449-1454
pubmed: 32217721
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
J Infect Dis. 2016 Oct 1;214 Suppl 2:S44-50
pubmed: 27625430
N Engl J Med. 1987 Jul 23;317(4):192-7
pubmed: 3299090
Blood. 2020 Oct 1;136(14):1606-1614
pubmed: 32736379
J Infect Dis. 2019 Jan 7;219(2):254-263
pubmed: 30032171
Blood. 2020 Oct 1;136(14):1590-1598
pubmed: 32746453
Cell Stem Cell. 2021 Aug 5;28(8):1428-1442.e6
pubmed: 33743191
J Mol Diagn. 2016 Nov;18(6):851-863
pubmed: 27637301
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Genome Biol. 2016 Feb 22;17:31
pubmed: 26899170
Arterioscler Thromb Vasc Biol. 2020 Jul;40(7):1787-1800
pubmed: 32460579
Nat Rev Cardiol. 2020 Mar;17(3):137-144
pubmed: 31406340
Retrovirology. 2018 Jan 29;15(1):13
pubmed: 29378657
Nat Genet. 2020 Nov;52(11):1219-1226
pubmed: 33106634
PLoS One. 2019 Feb 13;14(2):e0211961
pubmed: 30759116
Am J Hum Genet. 2017 Jul 6;101(1):50-64
pubmed: 28669404
Hum Mutat. 2017 Feb;38(2):226-235
pubmed: 27767231
Nat Med. 2021 Jun;27(6):1012-1024
pubmed: 34099924
Cell Host Microbe. 2020 Apr 8;27(4):519-530
pubmed: 32272077
Anal Bioanal Chem. 2015 Jul;407(19):5827-34
pubmed: 26022094
J Antimicrob Chemother. 2019 Oct 1;74(10):3030-3034
pubmed: 31314108
JCI Insight. 2021 Apr 8;6(7):
pubmed: 33630761
Nature. 2020 Feb;578(7793):94-101
pubmed: 32025018
Nat Rev Cardiol. 2020 Dec;17(12):828
pubmed: 32616879
JAMA Netw Open. 2020 Jun 1;3(6):e207954
pubmed: 32539152
J Acquir Immune Defic Syndr (1988). 1993 Jun;6(6):541-9
pubmed: 8496786
Circ Res. 2018 Feb 2;122(3):523-532
pubmed: 29420212
Exp Gerontol. 2007 May;42(5):432-7
pubmed: 17307327
N Engl J Med. 2014 Dec 25;371(26):2488-98
pubmed: 25426837

Auteurs

Wouter A van der Heijden (WA)

Department of Internal Medicine, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.

Rosanne C van Deuren (RC)

Department of Internal Medicine, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.

Lisa van de Wijer (L)

Department of Internal Medicine, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.

Inge C L van den Munckhof (ICL)

Department of Internal Medicine, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.

Marloes Steehouwer (M)

Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.

Niels P Riksen (NP)

Department of Internal Medicine, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.

Mihai G Netea (MG)

Department of Internal Medicine, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Department for Genomics and Immunoregulation, Life and Medical Sciences Institute, University of Bonn, Bonn, Germany.

Quirijn de Mast (Q)

Department of Internal Medicine, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.

Linos Vandekerckhove (L)

HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent, Belgium.

Richarda M de Voer (RM)

Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.

Andre J van der Ven (AJ)

Department of Internal Medicine, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.

Alexander Hoischen (A)

Department of Internal Medicine, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH